Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-FLUCONAZOLE | Resolved | 2018-01-18 | 2018-05-04 | 36496 | ||
APO-DIPYRIDAMOLE | Resolved | 2018-08-21 | 2018-09-17 | 58589 | ||
APO-CEFPROZIL | Resolved | 2018-09-28 | 2019-06-12 | 62614 | ||
APO-CEFPROZIL | Resolved | 2018-09-28 | 2019-05-24 | 62618 | ||
APO-CANDESARTAN | Resolved | 2020-03-09 | 2020-05-04 | 108228 | ||
APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2020-08-14 | 2020-11-18 | 122276 |
APO-FLUCONAZOLE-150 | 150MG | CAPSULE CAPSULE | Resolved | 2021-05-25 | 2021-09-20 | 139837 |
APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2022-12-09 | 2023-01-31 | 177609 |
APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2023-02-02 | 2023-02-09 | 183489 |
APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2023-08-18 | 2023-09-12 | 202406 |
APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2017-03-10 | 2017-07-20 | 61 |
APO-ATOMOXETINE | 60MG | CAPSULE | Resolved | 2017-03-10 | 2017-07-20 | 64 |
APO-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2017-03-10 | 2017-05-27 | 119 |
APO-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2017-03-10 | 2017-10-30 | 122 |
APO-PREGABALIN | 150MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-10 | 447 |
APO-PREGABALIN | 50MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-10 | 450 |
APO-PREGABALIN | 75MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-10 | 456 |
APO-RIVASTIGMINE | 4.5MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-18 | 487 |
APO-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2017-03-11 | 2017-04-12 | 534 |
APO-GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-03-11 | 2017-03-29 | 604 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
APO-LISINOPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
APO-LISINOPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
APO-LISINOPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60600 |
APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |
APO-MEDROXY TABLETS | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60609 |
APO-MELOXICAM | 7.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60612 |
APO-MEMANTINE | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60615 |
APO-METOPROLOL | 25MG | TABLET | To be discontinued | 2018-09-07 | 2021-06-03 | 60628 |
APO-METOPROLOL | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-01-09 | 60631 |
APO-METOPROLOL (TYPE L) | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60634 |
APO-MYCOPHENOLATE | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-10-12 | 60640 |